Senti Biosciences (SNTI) Change in Accured Expenses (2021 - 2025)

Senti Biosciences has reported Change in Accured Expenses for 5 years, with the latest figure at $251000.0 in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses fell 87.64% year-over-year to $251000.0; the trailing twelve-month figure through Dec 2025 stood at $559000.0 (up 183.31% YoY), and the FY2025 full-year result was $559000.0, up 183.31% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at $251000.0, down from $1.5 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.0 million in Q4 2024, with the low at -$2.9 million in Q1 2024.
• Average Change in Accured Expenses over 5 years is $136765.4, with a median of $36466.0 recorded in 2021.
• Peak annual rise in Change in Accured Expenses reached 68753.86% in 2022, while the deepest fall reached 137551.36% in 2022.
• Tracing SNTI's Change in Accured Expenses over 5 years: stood at $39520.0 in 2021, then jumped by 1334.72% to $567000.0 in 2022, then soared by 237.04% to $1.9 million in 2023, then advanced by 6.28% to $2.0 million in 2024, then slumped by 87.64% to $251000.0 in 2025.
• The last three Change in Accured Expenses figures came in at $251000.0 (Q4 2025), $1.5 million (Q3 2025), and -$48000.0 (Q2 2025), per Business Quant data.

Peer Comparison